Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer.
Journal: Future oncology (London, England)
Published: June 25, 2026
Erratum: First-In-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 30, 2026
Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences.
Journal: Cancer communications (London, England)
Published: November 23, 2025
Identification of Targetable EGFR Mutations in Ovarian Cancer.
Journal: JCO precision oncology
Published: September 10, 2025
Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy.
Journal: JCO oncology practice
Published: June 02, 2025
A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 17, 2025
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 09, 2025
Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer.
Journal: Chest
Published: March 10, 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2025
Datopotamab deruxtecan-associated select adverse events: clinical practices and institutional protocols on prophylaxis, monitoring, and management.
Journal: The oncologist
Published: January 02, 2025
Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients.
Journal: Clinical lung cancer
Published: November 30, 2024
Last Updated: 09/26/2026